Health Canada has approved Sativex (Cannabis sativa L. extract) a new drug developed as adjunctive treatment for the symptomatic relief of neuropathic pain in adults with multiple sclerosis (MS).
WebProWorld
Headline
Tag: cannabis
Back To Top
WebProWorld
Health Canada has approved Sativex (Cannabis sativa L. extract) a new drug developed as adjunctive treatment for the symptomatic relief of neuropathic pain in adults with multiple sclerosis (MS).